62 related articles for article (PubMed ID: 38651852)
1. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada Disease: A Narrative Review.
Tayal A; Daigavane S; Gupta N
Cureus; 2024 Apr; 16(4):e58867. PubMed ID: 38800227
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada Disease: The Clinical Spectrum and Management of Case Series in a Tertiary Eye Centre in Northern Part Of Malaysia.
Hasan AN; Mustapha M; Wan HAHW
Cesk Slov Oftalmol; 2024; 80(3):140-144. PubMed ID: 38413229
[TBL] [Abstract][Full Text] [Related]
5. EDI-OCT as an auxiliary examination for the differential diagnosis of bullous CSC and Vogt-Koyanagi-Harada: A case report.
Zhang Y; Gui C; Wang T; Bai J; Wan Z; Gao L; Peng Q
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104061. PubMed ID: 38521148
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04.
Amagai R; Fujimura T; Yamazaki E; Takahashi M; Tamabuchi E; Kambayashi Y; Hashimoto A; Hashimoto K; Asano Y
J Dermatol; 2024 Jun; 51(6):854-857. PubMed ID: 38111371
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Analysis of Adalimumab Versus Cyclosporine for Vogt-Koyanagi-Harada Disease: A Randomized Controlled Study.
Dai L; Zhong Z; Wu Q; Gao Y; Lu X; Zhang F; Tang C; Wang Y; Zhou C; Yang P
Curr Eye Res; 2024 May; ():1-9. PubMed ID: 38783638
[TBL] [Abstract][Full Text] [Related]
8. Effect of the COVID-19 pandemic on Vogt-Koyanagi-Harada disease.
Muto T; Sakamoto M; Kusuda S; Haruyama Y; Machida S; Imaizumi S; Sekiryu T
Sci Rep; 2024 Jun; 14(1):13211. PubMed ID: 38851824
[TBL] [Abstract][Full Text] [Related]
9. Acute Noninfectious Anterior Ocular Inflammation Following Ranibizumab Biosimilar Intravitreal Injection in a Patient With Recent COVID-19 Vaccination.
Tetsumoto R; Matsumiya W; Sotani R; Kusuhara S; Nakamura M
Cureus; 2024 May; 16(5):e60356. PubMed ID: 38883010
[TBL] [Abstract][Full Text] [Related]
10. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
Wang JN; Zhang Y; Huang CY; Li K; Yu XB
BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
[TBL] [Abstract][Full Text] [Related]
11. A Case of Ocular Sarcoidosis Post-COVID-19 Vaccination.
Gandhi S; Paranjpe R; Radhakrishnan O; Goyal K; Goli KB
Cureus; 2023 Nov; 15(11):e49303. PubMed ID: 38903489
[TBL] [Abstract][Full Text] [Related]
12. Pattern of uveitis in a referral ophthalmology center in Northeastern Thailand.
Wannapanich T; Chuenchaem W; Luanratanakorn P; Laovirojjanakul W
J Ophthalmic Inflamm Infect; 2024 May; 14(1):23. PubMed ID: 38819497
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis-associated uveitis - A series from South India.
Babu K; Janardhana GC; Murthy KR
Indian J Ophthalmol; 2024 May; 72(5):681-686. PubMed ID: 38153980
[TBL] [Abstract][Full Text] [Related]
14. Subretinal Fibrosis Developing 10 Years After First Presentation with Chronic Ocular Sarcoidosis in a Child.
Mavris N; Jaouni T; Amer R
Ocul Immunol Inflamm; 2024 Jun; ():1-4. PubMed ID: 38865486
[TBL] [Abstract][Full Text] [Related]
15. Presumed Fungal Retinitis Following Adalimumab Therapy for Juvenile Idiopathic Arthritis: A Rare Case Report.
Kene R; Singhai P; Raman R; Dutta Majumder P
Ocul Immunol Inflamm; 2024 Jun; ():1-4. PubMed ID: 38856750
[TBL] [Abstract][Full Text] [Related]
16. Not everything is ischemic optic neuropathy.
Hernández RF; Rodriguez JEM; Trecu MS; Tariq Bhatti M
Surv Ophthalmol; 2024 May; ():. PubMed ID: 38796109
[TBL] [Abstract][Full Text] [Related]
17. A case report of pediatric-onset MS associated uveitis.
Mahdizad Z; Zarei M; Fakhredin H; Samiee R; Heidari H; Ebrahimiadib N
J Ophthalmic Inflamm Infect; 2024 May; 14(1):21. PubMed ID: 38811495
[TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis type II B complicated by optic disc swelling, pigmentary retinopathy and macular edema.
Olivieri C; Ricardi F; Coletto A; Marica V; Serafino S; Marolo P; Reibaldi M; Borrelli E
Eur J Ophthalmol; 2024 May; ():11206721241257967. PubMed ID: 38803202
[TBL] [Abstract][Full Text] [Related]
19. Ocular Inflammatory Disease as a Predictor for In-Hospital Mortality in Patients Hospitalized with Disseminated Tuberculosis.
Mehta S
Cureus; 2017 Jan; 9(1):e956. PubMed ID: 28168134
[TBL] [Abstract][Full Text] [Related]
20. Clinico-Epidemiological Profile of Vitiligo Among Patients Attending a Tertiary Care Centre of North-East India.
Saha DR; Roy S; Ahmed R; Mahanta P
Cureus; 2024 Apr; 16(4):e58804. PubMed ID: 38784306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
